Search

everythinglearnresearchcommunity

for

Search:↓

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Mutations in the hairless protein gene cause hair loss.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

Tirzepatide may improve hair loss by reducing insulin resistance.

Syntaxin 9 helps in transporting and signaling of the EGF receptor in skin and stomach cells.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The arrector pili muscle attaches to the extracellular matrix using α5β1 integrin and connects muscle cells using α1β1 integrin.

MPZL3 is important for controlling the hair growth cycle in mice and humans.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

LncRNA018392 helps goat skin cells grow by increasing CSF1R.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

The PP2A-B55α protein is essential for brain and skin development in embryos.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Scientists found new genetic areas that affect how rice root hairs grow and develop.

CXCR2 in skin cells promotes tumor growth.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

ROS may affect hair loss related to hormones.

MPZL3 protein helps control the size of oil glands and the growth of oil-producing cells in both mice and humans.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The PLP2 gene affects cashmere fiber quality in goats and is linked to hair growth and loss.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Mutations in hKAP1 genes may cause hereditary hair disorders.